Form 4: Light & Wonder Director Dr. Kneeland Youngblood Receives Equity Grant of Restricted Stock Units

Light & Wonder, Inc. Director Dr. Kneeland Youngblood was granted 2,391 restricted stock units as part of a compensation package, scheduled to vest by June 2026.

Summary

• Dr. Kneeland Youngblood, a Director of Light & Wonder, Inc. (LNW), was granted 2,391 Restricted Stock Units (RSUs).
• The transaction date for this grant was June 10, 2025.
• Each restricted stock unit converts into one share of Light & Wonder common stock.
• The RSUs are scheduled to vest on the earlier of two dates: the issuer's 2026 annual meeting of stockholders or June 10, 2026.
• Following this transaction, Dr. Youngblood beneficially owns 2,391 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. This is a routine compensation event for a director, which aligns their interests with shareholders, but does not indicate significant operational or financial news.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Future Outlook

The 2,391 Restricted Stock Units granted to Dr. Kneeland Youngblood are scheduled to vest on the earlier of Light & Wonder's 2026 annual meeting of stockholders or June 10, 2026, at which point they will convert into common stock.

Industry Context

The grant of Restricted Stock Units to a director is a common form of equity compensation across various industries, including the gaming and lottery industry where Light & Wonder operates. This practice is designed to align the interests of the board members with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of director compensation is a widely accepted and standard practice among publicly traded companies, including those in the gaming and technology sectors.
• The vesting schedule, typically tied to future service or performance, is also a common feature of such equity grants, ensuring continued commitment from board members.

Related Party Transactions

• The grant of Restricted Stock Units to Dr. Kneeland Youngblood, a Director of Light & Wonder, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors. This is a standard and disclosed form of executive and director compensation.

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director aims to align the director's financial interests with the long-term value creation for shareholders.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The Restricted Stock Units will vest on the earlier of the issuer's 2026 annual meeting of stockholders or June 10, 2026, converting into common stock.

Key Dates

Keywords

Light & Wonder, LNW, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Form 4, SEC Filing